Lexeo Therapeutics (LXEO) Q2 2024 Earnings

9MayConfirmed
Q4 2023
Q2 2024
-0.86
-0.81
-0.75
-0.7

Details

Expected EPS
-0.737913
Actual EPS
-0.77
Surprise EPS
-0.03
Surprise Percent
+4.35%

Description

Lexeo Therapeutics (LXEO) has reported earnings of -0.77 per share for Q2 2024.

0 Comments

Share your thoughts